Product Information
CLONAZEPAM 1 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.0250 per EA under NDC 72888015330. Its NADAC has been published 161 times since May 31, 2023.
Strength
1 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888015330
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLONAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA075468On Market Since
4/14/2022
Pharmacological Classes
Price Statistics
The NADAC for CLONAZEPAM 1 MG TABLET has been published 161 times since May 31, 2023, and over the history we have for it it has declined 24.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0250 per EA |
|---|---|
| All-time high | $0.0342 (Sep 13, 2023) |
| All-time low | $0.0248 (Feb 18, 2026) |
| 52-week high | $0.0302 |
| 52-week low | $0.0248 |
| Median price | $0.0299 |
| Average price | $0.0293 |
| Largest weekly change | +23.6% (Jun 19, 2024) |
| Weeks tracked | 161 |
| Tracking since | May 31, 2023 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLONAZEPAM 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 1 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.0250 per EA (NDC 72888015330), effective Jun 24, 2026.
How has the price of CLONAZEPAM 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLONAZEPAM 1 MG TABLET has declined 24.2%. It has been tracked across 161 weekly CMS publications since May 31, 2023.
What are the highest and lowest recorded NADAC prices for CLONAZEPAM 1 MG TABLET?
Since May 31, 2023, the NADAC for CLONAZEPAM 1 MG TABLET has ranged from a low of $0.0248 (Feb 18, 2026) to a high of $0.0342 (Sep 13, 2023), with a median of $0.0299 per EA.
Are there cheaper alternatives to CLONAZEPAM 1 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as CLONAZEPAM 1 MG TABLET, but none are currently priced below it.
Who manufactures CLONAZEPAM 1 MG TABLET?
CLONAZEPAM 1 MG TABLET (NDC 72888015330) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.
Related Drugs
Same classification